9430007A20Rik Inhibitors

Chemical inhibitors of AADACL4 family member 1 utilize a variety of mechanisms to impede the enzyme's function. Palmitoyl-CoA, for instance, engages in competitive inhibition with the acyl-CoA substrates normally processed by AADACL4 family member 1. By occupying the active site, Palmitoyl-CoA prevents the enzyme from catalyzing its natural reactions. Similarly, Methyl palmitate also acts as a competitive inhibitor; it mimics the enzyme's substrates, thereby blocking the active site and halting enzymatic action. On the other hand, Methyl arachidonyl fluorophosphonate and PF-3845 achieve irreversible inhibition by covalently binding to the serine residue within the active site of AADACL4 family member 1. This binding leads to a permanent modification that disrupts the enzyme's catalytic ability.

Other inhibitors affect AADACL4 family member 1 by different means. Tetrahydrolipstatin (Orlistat) also targets the serine residue in the active site, but does so in a way that leads to long-lasting inhibition, which is not easily reversible. Cerulenin and Aristolochic acid both interact with the enzyme's active site, however, Cerulenin mimics the fatty acid substrate to prevent catalysis, while Aristolochic acid simply blocks substrate access. Tipiracil is believed to inhibit by interacting with the catalytic residues, thus preventing the enzymatic process. Oleylamine takes a different approach by inserting into the lipid substrate recognition site, which disrupts the enzyme's functionality. RHC 80267 and URB602 both inhibit AADACL4 family member 1 through substrate competition, with RHC 80267 acting on similar enzymes as well, and URB602 potentially altering the enzyme's conformation leading to inhibition. Each of these inhibitors, despite their varied approaches, effectively hinders AADACL4 family member 1 from fulfilling its catalytic role.